September 2018 Share
We are excited to announce that we making our microbubble-based T cell and B cell isolation kits available for purchase to early access users. A radical simplification over existing technologies, the use of microbubbles enables users to perform the entire cell separation process within a single tube and without a magnet.
Akadeum has recently completed a beta testing program where key opinion leaders from across the United States performed testing and provided feedback.
“The results from our beta testing program were fantastic, and we already have testers becoming customers. As a result of the success of the program, we are scaling up to fully launch products in the early part of 2019,” said John Younger, Akadeum’s co-founder and chief science officer.
In addition to the isolation kits, we have made our BACS™ Streptavidin Microbubbles and Human Red Blood Cell Depletion Microbubbles available for purchase through this offering as well.
Key advantages of Akadeum’s microbubble products include:
For more information, contact us.
Ann Arbor-based biotech company, Akadeum Life Sciences, announced the release of seven new products based…